Drug profile · INN
rizatriptan benzoate
RIZATRIPTAN BENZOATE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
rizatriptan benzoate (RIZATRIPTAN BENZOATE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Frequently asked questions
What is rizatriptan benzoate?
rizatriptan benzoate (RIZATRIPTAN BENZOATE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for rizatriptan benzoate?
RIZATRIPTAN BENZOATE is a marketed brand name for rizatriptan benzoate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of rizatriptan benzoate?
rizatriptan benzoate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.